The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...
Automated quality checks and notifications ... Thermo Fisher QuantStudio, Roche Cobas, Agilent Bravo. Collaboration Tools: Slack, Microsoft Teams, and Gmail for instant notifications and task ...
Fasting glucose and triglyceride levels were measured enzymatically using automated biochemical analyzers, namely the Roche Cobas 6000 and Roche Modular P systems. These tools guarantee accurate ...
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...
Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...
But take heart: We’re living in the future, and you can easily automate a wide range of many everyday tasks, gaining back precious minutes and even hours. If your grocery list is pretty stable ...
The products are being recalled by the FDA for possible "benzene contamination." Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to ...
MANILA – The New NAIA Infra Corp. (NNIC) has introduced an automated parking system at the Ninoy Aquino International Airport (NAIA), starting at Terminal 3 on March 1 and at Terminals 1 and 2 ...
Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. “Even with daily use of these products for ...
Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...
LONDON — Looking to expand its obesity offerings, Roche on Wednesday said it had partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion in upfront cash.